Literature DB >> 27099440

Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.

Hong Shen1, Jun-Li Ma1, Yan Zhang1, Gan-Lu Deng1, Yan-Ling Qu1, Xiao-Ling Wu1, Jing-Xuan He1, Sai Zhang1, Shan Zeng1.   

Abstract

AIM: To investigate the effect of integrin-linked kinase (ILK) on proliferation, metastasis, and invasion of the colorectal cancer cell line SW480.
METHODS: In this study, the colorectal cancer cell line SW480 was stably transfected with ILK plasmids, and small interfering RNA (siRNA) was used to knockdown expression of nuclear factor (NF)-κB/p65. Methylthiazole tetrazolium (MTT) assay was performed to measure proliferation, and the wound healing migration assay and matrigel invasion assay were used to test the metastasis and invasion ability of SW480 cells. To explore the epithelial-mesenchymal transition (EMT) process, embryonic development, and the invasion and metastasis of tumors, the protein level of E-cadherin, vimentin, snail, and slug was detected by western blot. Immunofluorescence was also used to detect E-cadherin expression. Western blot was used to determine the level of phosphorylated-inhibitor of kappa B (IκB)a, inhibitor of gamma B (IγB)a, and nuclear factor kappa B (NF-κB) expressions and to explore the ILK signaling pathway.
RESULTS: Western blot results revealed that ILK expression significantly increased when ILK was overexpressed in SW480 cells (P < 0.05). Proliferation, metastasis, and invasion ability were improved in the vector-ILK group compared to the vector group (P < 0.05). Immunofluorescence results revealed that E-cadherin fluorescence intensity decreased after ILK was overexpressed (P < 0.05). Western blot results revealed that the protein expression of E-cadherin was reduced, while vimentin, snail, and slug were upregulated when ILK was overexpressed in SW480 cells (P < 0.05). In order to determine the role of the NF-κB signaling pathway in ILK overexpression promoted EMT occurrence, we overexpressed ILK in SW480 cells and found that levels of NF-κB/p65 and cytoplasmic phosphorylated-IκBa were increased and that cytoplasmic IкBa levels were decreased compared to the control group (P < 0.05). Furthermore, NF-κB/p65 knockout revealed that E-cadherin was increased in the overexpressed ILK group.
CONCLUSION: ILK overexpression improved the proliferation, metastasis, and invasion ability of SW480 cells, and this effect may be mediated by the NF-κB signaling pathway.

Entities:  

Keywords:  Colorectal cancer; Epithelial-mesenchymal transition; Integrin-linked kinase; Nuclear factor-κB; Overexpression

Mesh:

Substances:

Year:  2016        PMID: 27099440      PMCID: PMC4823247          DOI: 10.3748/wjg.v22.i15.3969

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

2.  Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models.

Authors:  Daiana D Becker-Santos; Yubin Guo; Mazyar Ghaffari; Elaine D Vickers; Melanie Lehman; Manuel Altamirano-Dimas; Arusha Oloumi; Junya Furukawa; Manju Sharma; Yuzhuo Wang; Shoukat Dedhar; Michael E Cox
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

3.  The importance of integrin-linked kinase in the regulation of bladder cancer invasion.

Authors:  Yoshiyuki Matsui; Kiran Assi; Osamu Ogawa; Peter A Raven; Shoukat Dedhar; Martin E Gleave; Baljinder Salh; Alan I So
Journal:  Int J Cancer       Date:  2011-05-28       Impact factor: 7.396

4.  Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer.

Authors:  A Albasri; S Al-Ghamdi; W Fadhil; M Aleskandarany; Y-C Liao; D Jackson; D N Lobo; S H Lo; R Kumari; L Durrant; S Watson; K B Kindle; M Ilyas
Journal:  Oncogene       Date:  2011-02-21       Impact factor: 9.867

5.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

Authors:  Roger J Packer; Tianni Zhou; Emi Holmes; Gilbert Vezina; Amar Gajjar
Journal:  Neuro Oncol       Date:  2012-10-25       Impact factor: 12.300

6.  The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

Authors:  Peijun Liu; Jining Lu; Wellington V Cardoso; Cyrus Vaziri
Journal:  Mol Biol Cell       Date:  2007-11-07       Impact factor: 4.138

7.  Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation.

Authors:  Mykola Maydan; Paul C McDonald; Jasbinder Sanghera; Jun Yan; Charalampos Rallis; Sheena Pinchin; Gregory E Hannigan; Leonard J Foster; David Ish-Horowicz; Michael P Walsh; Shoukat Dedhar
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

8.  The integrin-linked kinase gene up-regulated by hypoxia plays its pro-survival role in colorectal cancer cells.

Authors:  Lei Xiao; Xiaolong Yue; Xiaodong Ming; Lishan Xu; Mingfeng Ding; Jun Xu; Qian Liu
Journal:  J Recept Signal Transduct Res       Date:  2013-12-03       Impact factor: 2.092

9.  Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.

Authors:  Stefan B Watzka; Florian Posch; Harvey I Pass; Raja M Flores; Gregory E Hannigan; David Bernhard; Michael Weber; Michael R Mueller
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-07       Impact factor: 4.191

10.  Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells.

Authors:  Y-P Yu; J-H Luo
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

View more
  15 in total

1.  New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis.

Authors:  Paul C McDonald; Shoukat Dedhar
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

2.  Integrated Analysis Reveals the Gut Microbial Metabolite TMAO Promotes Inflammatory Hepatocellular Carcinoma by Upregulating POSTN.

Authors:  Yonglin Wu; Xingyu Rong; Miaomiao Pan; Tongyao Wang; Hao Yang; Xiejiu Chen; Zhenming Xiao; Chao Zhao
Journal:  Front Cell Dev Biol       Date:  2022-05-23

3.  Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway.

Authors:  Ting Xu; Xiao-Li Ma; Yu Wei; Lei-Yu Cao; Yan Gao; Juan Liu; Li Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo.

Authors:  Yu-Shen Yang; Dan Wen; Xue-Feng Zhao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

5.  Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme.

Authors:  Dieter Henrik Heiland; Carl Philipp Simon-Gabriel; Theo Demerath; Gerrit Haaker; Dietmar Pfeifer; Elias Kellner; Valerij G Kiselev; Ori Staszewski; Horst Urbach; Astrid Weyerbrock; Irina Mader
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

6.  Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway.

Authors:  Jingjing Lu; Ying Xu; Xuan Wei; Zhe Zhao; Jing Xue; Peishu Liu
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

7.  C14orf159 suppresses gastric cancer cells' invasion and proliferation by inactivating ERK signaling.

Authors:  Yan-Mei Zhu; Qiang Li; Xiao-Zhuo Gao; Xiao Meng; Li-Li Sun; Yu Shi; En-Tian Lu; Yong Zhang
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

8.  Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo.

Authors:  Jingjing Lu; Ying Xu; Zhe Zhao; Xiaoning Ke; Xuan Wei; Jia Kang; Xuan Zong; Hongluan Mao; Peishu Liu
Journal:  Onco Targets Ther       Date:  2017-07-19       Impact factor: 4.345

9.  ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.

Authors:  Cao Guo; Junli Ma; Ganlu Deng; Yanlin Qu; Ling Yin; Yiyi Li; Ying Han; Changjing Cai; Hong Shen; Shan Zeng
Journal:  J Cancer       Date:  2017-09-30       Impact factor: 4.207

10.  Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer.

Authors:  Weifang Jiang; Weiji Yang; Li Yuan; Fanlong Liu
Journal:  Onco Targets Ther       Date:  2018-10-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.